Results 211 to 220 of about 108,706 (253)

Multimodal Conversion Therapy Enabling Curative Resection in Giant Hepatocellular Carcinoma with Arteriovenous Fistula: A Case Report. [PDF]

J Hepatocell Carcinoma
Zhong H, Tan L, Le W, Luo N, Shen Y, Long G, Xiong C, Tao H.   +7 more
europepmc   +1 more source

tRF-34-P4R8YP9LON4VHM may serve as a promising potential diagnostic biomarker for hepatocellular carcinoma. [PDF]

Sci Rep
Guo Y, Huang M, Lu Y, Xu T, Ge X, Huang Y, Zong W, Ni K.   +7 more
europepmc   +1 more source

Repeated measurements of alpha fetoprotein and fibrosis-4 predict long term hepatocellular carcinoma and mortality risks after antiviral therapy. [PDF]

Infect Med (Beijing)
Yu M, Zhou H, Ma X, Xia H, Zhang H, Lu Y, Chen H, Yu R, Wang Y, Huang P.   +9 more
europepmc   +1 more source

Alpha-Fetoprotein (AFP) and AFP-L3 Is Most Useful in Detection of Recurrence of Hepatocellular Carcinoma in Patients after Tumor Ablation and with Low AFP Level

Viruses, 2022
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and is a leading cause of mortality worldwide. While there are many risk factors for HCC including alcohol, obesity, and diabetes, hepatitis B virus (HBV) and hepatitis C ...
Madison Force, Divya Chalikonda, Christopher G Roth   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation

Journal of Hepatology, 2023
Background & Aims: Alpha-fetoprotein (AFP) predicts hepatocellular carcinoma (HCC) recurrence after liver transplant (LT) but remains an imperfect biomarker.
Joshua S Norman, P Jonathan Li, Prashant Kotwani   +2 more
exaly   +2 more sources